Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain by Luis Cordero Puentes, Carlota Moya de Alarcón, David Carcedo, Jordi Ginés Rubió, Maria del Carmen Garcías de España, Laura Delgado-Ortega

Subjects: Get full text

Colon-Targeted Poly(ADP-ribose) Polymerase Inhibitors Synergize Therapeutic Effects of Mesalazine Against Rat Colitis Induced by 2,4-Dinitrobenzenesulfonic Acid by Changyu Kang, Jaejeong Kim, Yeonhee Jeong, Jin-Wook Yoo, Yunjin Jung

Subjects: “…poly(ADP-ribose) polymerase inhibitor…”
Get full text

Efficacy and safety of angiogenesis inhibitors combined with poly ADP ribose polymerase inhibitors in the maintenance treatment of advanced ovarian cancer: a meta-analysis by Renming Huang, Feng Ji, Leyi Huang, Yueying Qin, Zhiyu Liang, Miaoyan Huang, Chunyan Li, Jian Ban

Subjects: Get full text

Poly (ADP-Ribose) Polymerase Inhibitor Olaparib-Resistant <i>BRCA1</i>-Mutant Ovarian Cancer Cells Demonstrate Differential Sensitivity to PARP Inhibitor Rechallenge by Chi-Ting Shih, Tzu-Ting Huang, Jayakumar R. Nair, Kristen R. Ibanez, Jung-Min Lee

Subjects: “…poly (ADP-ribose) polymerase inhibitor resistance…”
Get full text

A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis by Shiya Ji, Lu Chen, Yebo Yu, Xupeng Chen, Liwen Wei, Lili Gou, Cheng Shi, Susu Zhuang

Subjects: Get full text